2 active trials 2 recruiting 1 Phase 3 2 disease areas
| Phase 2 | 1 | |
| Phase 3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT06377852 | The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study | Metastatic Breast Cancer | Recruiting | 2026-06-29 |
| Phase 2 | ||||
| NCT02693535 | TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a… | Lymphoma, Non-Hodgkin | Recruiting | 2026-05-29 |
Multiple Myeloma (1) · Breast Cancer (1)